SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells

doi:10.3748/wjg.v17.i44.4922

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3321)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

301

HTML

2852

Figures (1-4)

168

Sum=3321

Nov 28, 2011 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 28, 2011; 17(44): 4922-4927
Published online Nov 28, 2011. doi: 10.3748/wjg.v17.i44.4922

Full Size Figure Download Figure

Figure 3 Knockdown of SOX7 counteracts the growth inhibitory effect of aspirin in SW480 cells. A: Western blotting verification of the interfering efficiency of SOX7 Short interfering RNA in aspirin-treated SW480 cells. β-actin was used as the internal reference; B: Effect of SOX7 knockdown on SW480 cell proliferation after treatment with different doses of aspirin for 48 h by moto-nuclear cell direc cytotoxicity assay assay. MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide.

Citation: Zhou X, Huang SY, Feng JX, Gao YY, Zhao L, Lu J, Huang BQ, Zhang Y. SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells. World J Gastroenterol 2011; 17(44): 4922-4927
URL: https://www.wjgnet.com/1007-9327/full/v17/i44/4922.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i44.4922